These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 7541258
21. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Tulassay Z, Döbrönte Z, Prónai L, Zágoni T, Juhász L. Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400 [Abstract] [Full Text] [Related]
25. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage. Nakatsuka A, Yamaguchi K, Chijiiwa K, Tanaka M. Int Surg; 2000 Nov; 85(2):124-9. PubMed ID: 11071328 [Abstract] [Full Text] [Related]
26. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Am J Gastroenterol; 1994 Mar; 89(3):327-33. PubMed ID: 8122639 [Abstract] [Full Text] [Related]
27. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats. Paran H, Klausner J, Siegal A, Graff E, Freund U, Kaplan O. J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640 [Abstract] [Full Text] [Related]
29. The effect of octreotide (SMS 201-995) on experimentally induced pancreatitis with 50% ethyl alcohol in rats. Korun N, Yilmazlar T, Kaya E, Kutlay B. Int Surg; 1994 May; 79(2):148-51. PubMed ID: 7523326 [Abstract] [Full Text] [Related]
30. Effect of octreotide on the prevention of hyperamylasemia after ERCP in Saudi Arabia: a prospective study. Al Awad N. Saudi J Gastroenterol; 2000 Jan; 6(1):37-40. PubMed ID: 19864727 [Abstract] [Full Text] [Related]
32. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Testoni PA, Bagnolo F. Gastrointest Endosc; 2001 Jan; 53(1):33-9. PubMed ID: 11154486 [Abstract] [Full Text] [Related]
33. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial. Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B. Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788 [Abstract] [Full Text] [Related]
36. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. Tsuchiya T, Itoi T, Sofuni A, Itokawa F, Kurihara T, Ishii K, Tsuji S, Kawai T, Moriyasu F. J Hepatobiliary Pancreat Surg; 2007 Jun; 14(3):302-7. PubMed ID: 17520207 [Abstract] [Full Text] [Related]
37. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy. Closset J, Journe S, Mboti F, El Nakadi I, Gelin M. Hepatogastroenterology; 2008 Jun; 55(86-87):1818-23. PubMed ID: 19102400 [Abstract] [Full Text] [Related]
39. Does endoscopic sphincterotomy cause prolonged pancreatobiliary reflux? Sugiyama M, Atomi Y. Am J Gastroenterol; 1999 Mar; 94(3):795-8. PubMed ID: 10086668 [Abstract] [Full Text] [Related]
40. Botulinum toxin injection after biliary sphincterotomy. Gorelick A, Barnett J, Chey W, Anderson M, Elta G. Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]